Exelixis, Inc. (EXEL)
41.28
-0.59
(-1.41%)
USD |
NASDAQ |
Dec 10, 12:49
Exelixis Market Cap: 11.07B for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vanda Pharmaceuticals, Inc. | 385.31M |
| ADMA Biologics, Inc. | 4.728B |
| Aldeyra Therapeutics, Inc. | 285.17M |
| Merck & Co., Inc. | 241.72B |
| ACADIA Pharmaceuticals, Inc. | 4.539B |
Market Cap Related Metrics
| PE Ratio | 17.38 |
| PS Ratio | 5.162 |
| PEG Ratio | 0.3383 |
| Price to Book Value | 5.122 |
| Price to Free Cash Flow | 15.15 |
| Price | 41.28 |
| Earnings Yield | 5.75% |
| PEGY Ratio | 0.3383 |
| Operating PE Ratio | 14.40 |
| Normalized PE Ratio | 17.02 |